Focuses on the use of a spectrophotometric screening assay to detect paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes. Method used to determine the sensitivity of the assay; Disadvantage of using monoclonal antibodies as a screening assay; Advantage of aerolysin assay in diagnosing PNH.